Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New E-Health system aims to keep tabs on chronic patients remotely

NCT ID NCT02803489

Knowledge-focused Sponsor: Air Liquide Santé International Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This pilot study tested an e-health system that uses tele-monitoring, tele-notification, and tele-coaching to help manage adults with at least two chronic conditions like heart failure, COPD, or diabetes. The goal was to see how well the system could detect health problems early. Only 23 people took part, and the study was stopped early, so results are limited.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nomhad Mobile - Nomhad Chronic (e-health system)
What this could lead to
If successful, this could lead to better remote monitoring tools for people with multiple chronic conditions, potentially reducing hospital visits.
What could go wrong
This was a small, early pilot study with only 23 participants and was terminated early. Results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

23 people

The number who actually took part.

Started

Apr 2016

Finished

May 2017

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Patients presenting all the following characteristics are eligible for inclusion: 1. Adult (\>18 yrs), male or female 2. Presenting at least two chronic diseases among the following three: chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes 3. Having been hospitalized in the CHANGE or in any other medical care center (hospital or private clinic) for acute decompensation of CHF or exacerbation of COPD at least once during the 12 months prior to inclusion 4. Able to speak and understand French to a satisfactory standard 5. Having a phone land line 6. Capable of understanding and accepting the study constraints 7. Having signed a written informed consent after a full explanation of the study by the investigator prior to inclusion Exclusion Criteria: Patients presenting any one of the following characteristics are not eligible for inclusion: 1. Pregnant or breast-feeding woman 2. Institutionalized 3. Having a life expectancy of less than 3 months 4. Receiving or having received chemotherapy or radiotherapy for cancer within the past 6 months 5. Undergoing dialysis for chronic renal insufficiency 6. Presenting a condition likely to hamper accomplishment of the study procedures, such as chronic alcoholism, drug or solvent addiction, uncontrolled psychiatric disease or severe cognitive deficiency 7. Not covered by French Social Security 8. Participating or having participated in another interventional trial within the past 30 days

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease chronic obstructive pulmonary disease congestive heart failure diabetes mellitus heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic diseases

Contacts and locations

Locations

  • Cabinet Privé de Cardiologie - 2, rue jean jaurès

    Annecy, 74000, France

  • Cabinet Privé de Pneumologie - 7 rue gabriel de mortillet

    Annecy, 74000, France

  • Cabinet privé de pneumologie - 28 avenue de Genève

    Saint-Julien-en-Genevois, 74160, France

  • Centre Hospitalier d'Annecy Genevois - service cardiologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy

    Pringy, 74374, France

  • Centre Hospitalier d'Annecy Genevois - service pneumologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy

    Pringy, 74374, France

  • cabinet privé de médecine générale - 18, rue Louis Haase

    Thônes, 74230, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.